The Initial Part of Polymorphic Ventricular Tachycardia as a Clue for the Sustainability of Tachycardia and Ablation Success: A Varying Degree of Purkinje-Myocardial Complicity?

Multiple exits Purkinje myocardial substrate pleomorphic ventricular tachycardia polymorphic ventricular tachycardia

Journal

The Journal of innovations in cardiac rhythm management
ISSN: 2156-3977
Titre abrégé: J Innov Card Rhythm Manag
Pays: United States
ID NLM: 101589872

Informations de publication

Date de publication:
Jun 2023
Historique:
received: 24 07 2022
accepted: 26 09 2022
pubmed: 30 6 2023
medline: 30 6 2023
entrez: 30 6 2023
Statut: epublish

Résumé

The cardiac Purkinje system is capable of very rapid burst activity suggestive of its potential role in being a driver of polymorphic ventricular tachycardia (VT) (PMVT) or ventricular fibrillation (VF). It plays a pivotal role, however, not only in the triggering of but also the perpetuation of ventricular arrhythmias. A varying degree of Purkinje-myocardial complicity has been blamed in determining not only the sustained or non-sustained nature of PMVT but also the pleomorphism of the non-sustained runs. The initial part of PMVT before cascading to the whole ventricle to establish disorganized VF can give important clues for ablation of PMVT and VF. We present a case of an electrical storm after acute myocardial infarction that was successfully ablated after identifying Purkinje potentials that triggered polymorphic, monomorphic, and pleiomorphic VTs and VF.

Identifiants

pubmed: 37388422
doi: 10.19102/icrm.2023.14066
pii: icrm.2023.14066
pmc: PMC10306249
doi:

Types de publication

Case Reports

Langues

eng

Pagination

5472-5480

Informations de copyright

Copyright: © 2023 Innovations in Cardiac Rhythm Management.

Déclaration de conflit d'intérêts

The authors report no conflicts of interest for the published content. No funding information was provided. This case was presented December 10, 2022 at the EP Finishing School.

Auteurs

Duygu Kocyigit Burunkaya (D)

Department of Cardiology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.

Ozcan Ozeke (O)

Department of Cardiology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.

Ahmet Korkmaz (A)

Department of Cardiology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.

Firat Ozcan (F)

Department of Cardiology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.

Meryem Kara (M)

Department of Cardiology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.

Elif Hande Ozcan Cetin (EH)

Department of Cardiology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.

Mehmet Yaman (M)

Department of Cardiology, Eregli Echomar Hospital, Zonguldak, Turkey.

Can Demirhan (C)

Department of Cardiology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.

Abdullah Tuncez (A)

Department of Cardiology, Selcuk University, Konya, Turkey.

Umuttan Dogan (U)

Department of Cardiology, Akdeniz University, Antalya, Turkey.

Osman Can Yontar (OC)

Department of Cardiology, University of Health Sciences, Samsun Education and Research Hospital, Samsun, Turkey.

Serkan Cay (S)

Department of Cardiology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.

Dursun Aras (D)

Department of Cardiology, Istanbul Medipol University, Istanbul, Turkey.

Serkan Topaloglu (S)

Department of Cardiology, University of Health Sciences, Ankara City Hospital, Ankara, Turkey.

Classifications MeSH